The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by BAKKER, A.
* Articles by VAN DYCK, R.
* Search for Related Content
PubMed
* Articles by BAKKER, A.
* Articles by VAN DYCK, R.
Related Collections
* Behavior Therapy
* Cognitive Therapy
* Miscellaneous Somatic Therapies
* Antidepressants
* Anxiolytics
Am J Psychiatry 158:1164-1165, July 2001
© 2001 American Psychiatric Association


Letter to the Editor

Comparing Psychotherapy and Pharmacotherapy

ABRAHAM BAKKER, M.D., PH.D., ANTON J.L.M. VAN BALKOM, M.D., PH.D., and RICHARD VAN DYCK, M.D., PH.D.
Amsterdam, the Netherlands

To the Editor: In an interesting review, Dr. Klein critically examined four meta-analyses "that claim to quantitatively compare the benefits of psychotherapy to pharmacotherapy in patients with psychiatric disorders" (p. 1204). The article dealt with some important aspects of meta-analyses that must be taken into account in evaluating their conclusions. For example, Dr. Klein correctly pointed out the economic and ideological consequences that may play a role in claims derived from meta-analyses. Although we agree that a meta-analysis is no substitute for direct comparisons in adequately designed studies, we have some remarks concerning his selection of the meta-analyses discussed and his comments.

First, he discussed two meta-analyses of panic disorder that were published in 1995 and 1989 but paid no attention to our more recent meta-analyses from 1997 and 1998 (1, 2). In these studies, we addressed several criticisms that he made. We did control for a possible publication bias toward positive results (it probably would not change the conclusions for panic disorder), checked for potential differences between a wait-listed control group and a placebo group (we found comparable effect sizes), and performed quality assessments (we found no relationship between quality and outcome). In both meta-analyses, we found that the combination of antidepressants and exposure in vivo was superior to either therapy given separately.

Second, Dr. Klein discussed our meta-analysis of treatments for obsessive-compulsive disorder (OCD) (3) and criticized the noncomparative effect size we used because it was "vulnerable to several artifacts" (p. 1208) without specifying these artifacts. He also stated that "since only one of the 86 studies directly compared psychological with pharmacological interventions and showed no significant a priori distinctions between the two treatments, this conclusion [that behavior therapy is more effective for the treatment of OCD than antidepressants] goes far beyond the data" (p. 1208). As we pointed out in the introduction of the article, the scarcity of direct comparisons was precisely the reason we undertook the meta-analysis: as a next-best answer to the question of relative efficacy. Unfortunately, to our knowledge, even to this date no direct comparisons of antidepressants and cognitive behavior therapy in OCD have been published. We hope that the field picks up the recommendation to conduct comparative studies in both fields.

References

  1. van Balkom AJLM, Bakker A, Spinhoven PH, Blaauw BMJW, Smeenk S, Ruesink B: A meta-analysis of the treatment of panic disorder with or without agoraphobia. J Nerv Ment Dis 1997; 185:510-516[CrossRef][Medline]
  2. Bakker A, van Balkom AJLM, Spinhoven PH, Blaauw BMJW, van Dyck R: Follow-up on the treatment of panic disorder with or without agoraphobia. J Nerv Ment Dis 1998; 186:414-419[CrossRef][Medline]
  3. van Balkom AJLM, van Oppen P, Vermeulen AWA, van Dyck R, Nauta MCE, Vorst HCM: A meta-analysis on the treatment of obsessive compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev 1994; 14:359-381




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by BAKKER, A.
* Articles by VAN DYCK, R.
* Search for Related Content
PubMed
* Articles by BAKKER, A.
* Articles by VAN DYCK, R.
Related Collections
* Behavior Therapy
* Cognitive Therapy
* Miscellaneous Somatic Therapies
* Antidepressants
* Anxiolytics


Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org